Gallbladder Cancer: A Comprehensive Guide to Management (膽囊癌：全面管理指南)

《膽囊癌：管理的綜合指南》旨在提供一部全面且客觀的膽囊癌專著，涵蓋從流行病學和發病機制到當前尖端技術和持續研究的各個方面。

本書提供了一個全球範圍內疾病的綜合回顧，匯聚了來自不同大陸的知名研究者，並包括了有關膽囊癌管理的關鍵主題的最新討論。

流行病學內容涵蓋流行病學數據、隨時間變化的趨勢、風險因素、發病率和癌症特定的死亡率。各章節描述了與病因機制、基因組學、蛋白質組學和轉錄組學相關的內在分子機制。關於預防，書中介紹了預防措施和藥物的預防性使用。各章節還描述了不同形式膽囊癌的臨床、放射學和實驗室方面。此外，書中探討了生物標記在診斷、預後和隨訪中的作用。讀者還會發現有關多學科治療管理、外科爭議、全身治療和放射治療等主題。

本書是一般外科醫生、癌症外科醫生、肝膽胰外科醫生、臨床腫瘤學家、腸胃病學家及醫學住院醫師的重要資源。

Mauro M. Correia, MD, PhD: MD from the Federal University of Rio de Janeiro State (Unirio, Brazil, 1984). He completed residencies in general surgery at UFRJ (1987) and in surgical oncology at the National Cancer Institute (Brazil, 1989). Master (1991) and PhD (1997) in general surgery from the Federal University of Rio de Janeiro (UFRJ, Brazil). Oncologic Digestive Endoscopy fellowship at UFF-INCA (1990). Observation HPB Fellow Scholarship at Memorial Sloan Kettering Cancer Center (USA, 1995). Postdoctoral fellowship at Wakefield Clinic (New Zealand, 2004). He coordinated the Medical Residency Program at the National Cancer Institute (Brazil), where he also founded the Liver Group and introduced ablative methods and IOUS. He founded the Brazilian Chapter of the IHPBA. He is a fellow of the Brazilian College of Surgeons, Emeritus President of the Brazilian Chapter of IHPBA and fellow of the Brazilian Society of Surgical Oncology. He has been head of the Surgical Department at UNIGRANRIO University for 23 years. His research has contributed to developing medical educational imaging, navigated liver surgery with augmented reality and epidemiological research on colorectal liver metastases. Dr Correia has coordinated the production of the first Treatise of Oncology in Brazil, gathering 400 national and international collaborators in 2013 and is author to other 10 books and 46 book chapters in Portuguese, Spanish and English in the area of Surgical Oncology (Gastric Cancer; Hepatobiliary Cancer Surgery). He has also written many scientific papers and is member of the editorial board of the REVISTA BRASILEIRA DE CANCEROLOGIA and ACTA SCIENTIAE ANATOMICA.

Michael A. Choti, MD: Dr. Choti received his MD degree from Yale University, general surgery training at the University of Pennsylvania, and completed the surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center before joining the division of Surgical Oncology at Johns Hopkins. Among his leadership roles, he was the Chair of Surgery at the University of Texas Southwestern Medical Center. Currently, he is the Chief of Surgery at Banner MD Anderson Cancer Center in Phoenix, Arizona. Dr. Choti is an active clinician and researcher with an interest in new approaches for the treatment of liver and colorectal cancer. He has served on various leadership positions in national and international societies and has chaired study sections for the American Cancer Society. He served as Chair of the NCI-CTEP Hepatobiliary Task Force as well as on the American College of Surgeons' Commission on Cancer, the GI committees of NSABP and ACOSOG, and the Colorectal Cancer Guideline Panel of NCCN. He has directed educational symposia and served on program committees for ASCO, SSO, AACR, among others. He also was a Section Editor for the Annals of Surgical Oncology. Currently, he is on the Surgical Oncology Board for the American Board of Surgery.

Dr. Rocha, is the Hedinger Professor and Chair of Surgical Oncology at Oregon Health and Science University (OHSU) in Portland, OR. He also serves as the Physician-in-Chief of the Knight Cancer Institute at OHSU. He graduated with honors from the University of Chicago Pritzker School of Medicine. After training in general surgery at the Brigham and Women's Hospital and Harvard Medical School both in Boston, he completed both a surgical oncology and hepatopancreatobiliary surgery fellowship at Memorial Sloan-Kettering Cancer Center in New York City. He spent ten years practicing in Seattle prior to moving to Oregon in 2021. Dr. Rocha's clinical practice encompasses all aspects of benign and malignant disease of the liver, bile ducts and pancreas. He has been funded by the AAS, NIH/NIDDK, ASCO and the Cholangiocarcinoma Foundation. Dr. Rocha currently sits on the editorial boards of Surgery, HPB, Annals of Surgical Oncology, and Journal of Surgical Oncology. He has served on the NCI Pancreas Task Force, ASCO Gastrointestinal Cancers Advisory Council and ASTRO Liver Cancer Guidelines Committee. He is currently the surgical lead of the International Cholangiocarcinoma Research Network (ICRN), Vice-Chair of the Southwest Oncology Group (SWOG) Surgery Committee, GI Surgery Working Group Chair at Eastern Cooperative Group (ECOG-ACRIN) and Chair of the Cancer Standards Development Committee at the American College of Surgeons.

Mauro M. Correia，醫學博士，博士：1984年自巴西里約熱內盧聯邦大學（Unirio）獲得醫學學位。他在UFRJ完成了一般外科的住院醫師訓練（1987年）以及在巴西國家癌症研究所完成了外科腫瘤學的住院醫師訓練（1989年）。他於1991年獲得一般外科碩士學位，1997年獲得博士學位，均來自巴西里約熱內盧聯邦大學（UFRJ）。他在UFF-INCA完成了腫瘤消化內視鏡的專科訓練（1990年）。他於1995年獲得美國紀念斯隆凱特琳癌症中心的觀察HPB獎學金。2004年，他在新西蘭的Wakefield Clinic完成了博士後研究。他協調了巴西國家癌症研究所的醫學住院醫師計畫，並在該所創立了肝臟小組，推廣消融技術和術中超聲（IOUS）。他創立了IHPBA的巴西分會。他是巴西外科醫師學會的會員，曾擔任IHPBA巴西分會的名譽會長，並是巴西外科腫瘤學會的會員。他在UNIGRANRIO大學的外科系擔任主任已有23年。他的研究對醫學教育影像、增強現實下的肝臟手術以及結直腸肝轉移的流行病學研究做出了貢獻。Correia醫生協調了巴西第一本腫瘤學專著的編寫，於2013年聚集了400位國內外合作者，並著有其他10本書及46章書籍，涵蓋葡萄牙語、西班牙語和英語的外科腫瘤學領域（胃癌；肝膽癌手術）。他還撰寫了許多科學論文，並擔任《巴西癌症學雜誌》和《解剖科學學報》的編輯委員會成員。

Michael A. Choti，醫學博士：Choti醫生在耶魯大學獲得醫學學位，並在賓夕法尼亞大學接受一般外科訓練，隨後在紀念斯隆凱特琳癌症中心完成外科腫瘤學專科訓練，然後加入約翰霍普金斯大學的外科腫瘤學部門。在他的領導角色中，他曾擔任德克薩斯大學西南醫學中心的外科系主任。目前，他是位於亞利桑那州菲尼克斯的Banner MD Anderson癌症中心的外科主任。Choti醫生是一位活躍的臨床醫生和研究者，對肝臟和結直腸癌的治療新方法充滿興趣。他曾在國內外學會中擔任各種領導職位，並主持美國癌症學會的研究小組。他曾擔任NCI-CTEP肝膽道工作小組的主席，以及美國外科醫師學會的癌症委員會、NSABP和ACOSOG的GI委員會，以及NCCN的結直腸癌指導小組。他曾主導教育研討會，並在ASCO、SSO、AACR等會議的計畫委員會中任職。他還擔任《外科腫瘤學年鑑》的部分編輯。目前，他是美國外科醫學委員會的外科腫瘤學委員會成員。

Rocha醫生是俄勒岡健康科學大學（OHSU）外科腫瘤學的Hedinger教授及主任。他同時擔任OHSU奈特癌症研究所的首席醫生。他以優異的成績畢業於芝加哥大學普利茨克醫學院。在波士頓的布萊根婦女醫院和哈佛醫學院接受一般外科訓練後，他在紐約市的紀念斯隆凱特琳癌症中心完成了外科腫瘤學和肝胰膽外科的專科訓練。他在西雅圖執業十年後於2021年搬到俄勒岡州。Rocha醫生的臨床實踐涵蓋肝臟、膽道和胰臟良性及惡性疾病的所有方面。他曾獲得AAS、NIH/NIDDK、ASCO和膽管癌基金會的資助。Rocha醫生目前擔任《外科》、《HPB》、《外科腫瘤學年鑑》和《外科腫瘤學雜誌》的編輯委員會成員。